ENOB Enochian Biosciences Inc

CUSIP No. 29350E104

_____________________________

¹ William Anderson Wittekind (“Wittekind”) and Carl Sandler (“Sandler”) share voting and dispositive power over such shares by virtue of their status as managers of Weird Science LLC (“Weird Science”) as of the date of the event reported herein.

² Based upon 36,173,924 shares of common stock outstanding as of September 28, 2018, as disclosed in the issuer’s Form 10-K filed with the Commission on October 1, 2018.

CUSIP No. 29350E104

_____________________________

³ Consists of 17,545,283 shares owned by Weird Science. Wittekind and Sandler share the power to vote and the power to dispose of such shares by virtue of their status as managers of Weird Science as of the date of the event reported herein.

⁴ Based upon 36,173,924 shares of common stock outstanding as of September 28, 2018, as disclosed in the issuer’s Form 10-K filed with the Commission on October 1, 2018.

EXPLANATORY NOTE

This Amendment No. 1 amends the Schedule 13D filed by Weird Science LLC, a California limited liability company (“Weird Science”) and William Anderson Wittekind, a member and manager of Weird Science (“Wittekind” and, together with Weird Science, the “Reporting Persons”), with respect to the shares of common stock, par value $0.0001 per share (“Common Stock”) of Enochian Biosciences Inc. (the “Issuer”) received by Weird Science pursuant to that certain Agreement and Plan of Merger dated January 12, 2018 (the “Merger Agreement”) by and among the Issuer (then known as DanDrit BioTech USA, Inc.), DanDrit Acquisition Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Issuer (“Merger Sub”), Enochian Biopharma, Inc., a Delaware corporation (“Target”), and Weird Science, in its capacity as the majority stockholder of the Target.

Capitalized terms used but not defined in this Amendment No. 1 have the meanings given to such terms in the initial Schedule 13D.

Upon the execution and delivery of the First Amended and Restated Limited Liability Company Operating Agreement of Weird Science on October 30, 2018, Gumrukcu became the owner of a majority of Weird Science’s limited liability company units and the voting rights of its members. As a result of such status, Gumrukcu may be deemed to control Weird Science for purposes of General Instruction C of Schedule 13D from and after October 30, 2018 and such status may be deemed to be a material change within the meaning of Rule 13d-2(a) under the 1934 Act (17 CFR 240.13d-2(a)). On these bases, information regarding Gumrukcu is being provided in response to Items 2-6 of Schedule 13D, as applicable, for so long as Weird Science is a Reporting Person in this Statement.

The address of the principal executive offices of the Issuer is 2080 Century Park East, Suite 906, Los Angeles, CA 90067-2012.

(a)       Serhat Daniel Gumrukcu.

(b)       Gumrukcu is a non-managing member of Weird Science and the inventor of the intellectual property licensed by Weird Science to the Target pursuant to the Weird Science License Agreement.

(c)       Gumrukcu’s business address is 8581 Santa Monica Blvd. #317 West Hollywood CA 90069.

(d)       On February 8, 2017 the Attorney General of the State of California filed a Felony Complaint For Arrest Warrant with the Superior Court in the State of California, County of Los Angeles, in People of the State of California v. Serhat Daniel Gumrukcu (Case No. BA452833). Gumrukcu was charged with fourteen (14) felony counts and, on January 25, 2018, with the approval of the Court he pled no contest to one count of second-degree commercial burglary, a felony, and was found guilty by the Court. All other charges were dismissed. Judgment was suspended, and he was placed on probation for a five-year period, and he paid restitution.

(e)       None.

(f)       Gumrukcu is a citizen of Turkey.

The Weird Science Consulting Agreement was terminated on July 9, 2018.

The Sandler Consulting Agreement expired on August 16, 2018.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Amendment No. 1 is true, complete and correct.

Date: May 19, 2023

6